TGF-β signalling and immunity in prostate tumourigenesis

Author： Diener Kerrilyn R   Need Eleanor F   Buchanan Grant   Hayball John D  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.2, 2010-02, pp. : 179-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TGF-&bgr;1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 26, 2012-09 ,pp. : 3874-3888

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting TGF-β signaling in cancer

By Katz Lior H  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 743-760

Informa Healthcare

Access to resources Recommend Favorite

TGF-β inhibitors for the treatment of cancer

By Lahn Michael   Kloeker Susanne   Berry Brandi S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 629-641

Informa Healthcare

Access to resources Recommend Favorite

From TGF-&bgr; to Cancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-01 ,pp. : 243-250

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-&bgr; Pathway as a Therapeutic Target in Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1301-1312

Bentham Science Publishers

Access to resources Recommend Favorite